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Background
Hydrogen sulfide (H2S) is a gas produced by respiratory
cells including smooth muscle cells and may play a role as
a gasotransmitter. We determined whether H2S levels in
serum or sputum supernatants could represent a biomaker
of asthma.
Methods
We measured H2S in induced sputum and serum sam-
ples of patients with severe and non-severe asthma and
of healthy subjects. H2S concentrations were measured
using a sulfide-sensitive electrode.
Results
H2S levels in induced sputum from severe and non-
severe asthmatic patients were significantly higher than
those from healthy subjects but there was no difference
between the severe and non-severe group. Serum H2S
levels were 10 times higher than in sputum and these
were also higher in severe and non-severe asthmatic
subjects compared to healthy subjects. There was a posi-
tive correlation between sputum and blood H2S levels
(r=0.42, p<0.05). Sputum H2S levels were negatively cor-
related with FEV1 %predicted (r=-0.42, p=0.003), and
with reversibility to salbutamol (r= -0.54, p<0.01). There
was a correlation between sputum H2S and sputum neu-
trophils and macrophages, and a negative correlation
between sputum H2S and FeNO levels.
Conclusions
Endogenous H2S, measured in induced sputum, may be
a marker of neutrophilic inflammation and bronchial
narrowing.
Published: 3 May 2013
doi:10.1186/2045-7022-3-S1-P3
Cite this article as: Saito et al.: Sputum and serum hydrogen sulfide
(H2S) as novel biomarker of asthma. Clinical and Translational Allergy 2013
3(Suppl 1):P3.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submitExperimental Studies, National Heart and Lung Institute, Imperial College
London & Biomedical Research Unit, Royal Brompton Hospital, London, UK
Saito et al. Clinical and Translational Allergy 2013, 3(Suppl 1):P3
http://www.ctajournal.com/content/3/S1/P3
© 2013 Saito et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
